Latest Li-Fraumeni syndrome Stories
Ohio State University researchers have discovered a hereditary cancer syndrome that predisposes certain people to a melanoma of the eye, along with lung cancer, brain cancer and possibly other types of cancer.
MK 1775, a small, selective inhibitor molecule, has been found to be active against many sarcomas when tested by researchers at Moffitt Cancer Center in Tampa, Fla.
Scientists at Joslin Diabetes Center in Boston have uncovered important molecular and genetic keys to the development of soft-tissue sarcomas in skeletal muscle, giving researchers and clinicians additional targets to stop the growth of these often deadly tumors.
Zeroing in on the early cell mutations that enable a cancer to grow is one of the best ways to find a personalized therapy to stop it.
Study suggests PET/CT may have value in screening Li-Fraumeni patients
- To swell, as grain or wood with water.